Amyloid β protein makes comeback as therapeutic target for Alzheimer's disease

For many years amyloid β protein was considered to be a promising therapeutic target in Alzheimer’s disease but, for a long time, research results were very disappointing.

Source link

Related posts

Sleep tight! Researchers identify the beneficial role of sleep


neurosciencenews: How Does Attention Impact False Memory…


Electrophysiologic Features Specific to Transthyretin Familial Amyloid Polyneuropathies


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy